This brand name is authorized in Cyprus
The drug BRALIX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Chlordiazepoxide
UNII 6RZ6XEZ3CR - CHLORDIAZEPOXIDE
|
|
Chlordiazepoxide has anxiolytic and central muscle relaxant properties. It has little autonomic activity. Chlordiazepoxide acts as depressant of the central nervous system producing all levels of CNS depression, from mild sedation to hypnosis, to coma depending on the dose. |
|
2
Clidinium
UNII 91ZQW5JF1Z - CLIDINIUM BROMIDE
|
|
Clidinium is a synthetic anticholinergic that has a spasmolytic effect on smooth muscle and also inhibits secretions. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A03CA02 | Clidinium and psycholeptics | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03C Antispasmodics in combination with psycholeptics → A03CA Synthetic anticholinergic agents in combination with psycholeptics |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
